EP Patent

EP2148864A2 — Fused-ring heterocycle opioids

Assigned to Rensselaer Polytechnic Institute · Expires 2010-02-03 · 16y expired

What this patent protects

Compounds of formula (I) are disclosed. In these compounds (1) or (2) is a heterocyclic ring. The compounds are useful as analgesics, anti-pruritics, anti-diarrheal agents, anticonvulsants, antitussives, anorexics/antiobesity agents and as treatments for hyperalgesia, drug addict…

USPTO Abstract

Compounds of formula (I) are disclosed. In these compounds (1) or (2) is a heterocyclic ring. The compounds are useful as analgesics, anti-pruritics, anti-diarrheal agents, anticonvulsants, antitussives, anorexics/antiobesity agents and as treatments for hyperalgesia, drug addiction, respiratory depression, dyskinesia, pain (including neuropathic pain), irritable bowel syndrome and gastrointestinal motility disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2148864A2
Jurisdiction
EP
Classification
—
Expires
2010-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Rensselaer Polytechnic Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.